November 8, 2001 — LAKEWOOD, NJ — The Classica Group, Inc. Classica Microwave Technologies, Inc. (CMT) subsidiary announced today the results of the tests conducted on October 25th, in its New Jersey laboratory facility to demonstrate that its technology will kill certain bacteria in mail.

The tests were conducted under the direct supervision of Robert H. Deibel, PhD., president and CEO of Deibel Laboratories, Inc., an independent microbiological and chemical testing laboratory company with facilities in Wisconsin, Illinois, California and Florida.

In the tests various sample pieces of mail were inoculated with a non-pathogenic strain of living bacteria and spores (genus Bacillus subtilus variety globigi) that, according to generally accepted microbiological theory, are one of the most difficult-to-kill organisms and an acceptable surrogate for other microbes, such as Bacillus anthracis, because the organisms are the same genus and somewhat related.

The report continues, “In the most significant results, the effects of the microwave treatment on the survival of Bacillus globigi spores on blotter paper, enclosed in standard business envelopes, were:

———————————————————————-

Processing Time (minutes) Total Count in Envelope (Spores)

———————————————————————-

0 208,000,000

———————————————————————-

5 1,600

———————————————————————-

10 Undetectable

———————————————————————-

15 Undetectable

———————————————————————-

“We could not be more pleased with the results of this first series of tests,” said Scott Halperin, The Classica Group, Inc.’s chairman and CEO. “At five minutes utilizing our laboratory system we experienced reduction in detectable spores from 208,000,000 to 1,600, a 99.9923 percent kill, at ten minutes there we no spores detectable. We find these results most encouraging and are planning further tests as we continue to refine our system for sale to the public as a sterilization system for mail,” he added.